These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7077932

  • 21. [The effect of various substances on the sensitivity of the heart to strophanthin in experimental myocardial infarct].
    Lazareva DN.
    Farmakol Toksikol; 1972; 35(6):695-8. PubMed ID: 4651802
    [No Abstract] [Full Text] [Related]

  • 22. [Adverse effect of strophanthin on the myocardium in patients with acute macrofocal and transmural myocardial infarct].
    Smolenskiĭ VS, Kun IS, Ostrovskaia VI, Mazel' GS.
    Sov Med; 1968 Jul; 31(7):73-7. PubMed ID: 5741652
    [No Abstract] [Full Text] [Related]

  • 23. [Strophanthin therapy of acute myocardial infarct].
    CRISTINI M.
    Minerva Med; 1961 Sep 26; 52():3306-9. PubMed ID: 13882253
    [No Abstract] [Full Text] [Related]

  • 24. [Clinico-electrocardiographic, morphological and biochemical manifestations of glycoside poisoning in patients with myocardial infarct].
    Popov VG, Smetnev AS, Lazutin VK, Beskrovnova NN, Zhelnov VV.
    Kardiologiia; 1977 Sep 26; 17(9):26-34. PubMed ID: 926596
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [BLOOD CIRCULATION MEASUREMENT IN EXPERIMENTAL MYOCARDIAL INFARCT AND ALTERATION OF THE BLOOD CIRCULATION IN THE INFARCTED AND NON-INFARCTED MYOCARDIUM BY SOME POISONS].
    LANGE G.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1963 Nov 30; 246():240-86. PubMed ID: 14096103
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Debatable questions of strophanthin and spironolactone treatment in certain forms of acute myocardial infarct].
    Kun IS, Ostrovskaia VI, Abinder AA.
    Kardiologiia; 1980 Dec 30; 20(12):14-8. PubMed ID: 7206422
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Use of strophanthin in the acute period of myocardial infarct].
    Tolstopiatov SM.
    Vrach Delo; 1980 Sep 30; (9):54-7. PubMed ID: 7423952
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
    Imagawa J, Yellon DM, Baxter GF.
    Br J Pharmacol; 1999 Feb 30; 126(3):701-8. PubMed ID: 10188982
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.